SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Jönsson Göran) "

Sökning: WFRF:(Jönsson Göran)

  • Resultat 1-25 av 393
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Jönsson, Jenny-Maria, et al. (författare)
  • Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome.
  • 2014
  • Ingår i: Familial Cancer. - : Springer Science and Business Media LLC. - 1389-9600 .- 1573-7292. ; 13:4, s. 537-545
  • Tidskriftsartikel (refereegranskat)abstract
    • Ovarian cancer linked to Lynch syndrome represents a rare subset that typically presents at young age as early-stage tumors with an overrepresentation of endometrioid and clear cell histologies. We investigated the molecular profiles of Lynch syndrome-associated and sporadic ovarian cancer with the aim to identify key discriminators and central tumorigenic mechanisms in hereditary ovarian cancer. Global gene expression profiling using whole-genome c-DNA-mediated Annealing, Selection, extension, and Ligation was applied to 48 histopathologically matched Lynch syndrome-associated and sporadic ovarian cancers. Lynch syndrome-associated and sporadic ovarian cancers differed by 349 significantly deregulated genes, including PTPRH, BIRC3, SHH and TNFRSF6B. The genes involved were predominantly linked to cell growth, proliferation, and cell-to-cell signaling and interaction. When stratified for histologic subtype, hierarchical clustering confirmed distinct differences related to heredity in the endometrioid and serous subtypes. Furthermore, separate clustering was achieved in an independent, publically available data set. The distinct genetic signatures in Lynch syndrome-associated and sporadic ovarian cancers point to alternative preferred tumorigenic routes and suggest that genetic discriminators may be relevant for molecular diagnostics and targeted therapeutics.
  •  
3.
  • Karlsson, Anna K, et al. (författare)
  • Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
  • 2014
  • Ingår i: Clinical Cancer Research. - 1078-0432. ; 20:23, s. 6127-6140
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose: Lung cancer is the worldwide leading cause of death from cancer. DNA methylation in gene promoter regions is a major mechanism of gene expression regulation that may promote tumorigenesis. However, whether clinically relevant subgroups based on DNA methylation patterns exist in lung cancer remains unclear. Experimental Design: Whole-genome DNA methylation analysis using 450K Illumina BeadArrays was performed on 12 normal lung tissues and 124 tumors including 83 adenocarcinomas, 23 squamous cell carcinomas (SqCC), one adenosquamous cancer, five large cell carcinomas, nine large cell neuroendocrine carcinomas (LCNEC), and three small cell carcinomas (SCLC). Unsupervised bootstrap clustering was performed to identify DNA methylation subgroups, which were validated in 695 adenocarcinomas and 122 SqCCs. Subgroups were characterized by clinicopathological factors, whole-exome sequencing data, and gene expression profiles. Results: Unsupervised analysis identified five DNA methylation subgroups (epitypes). One epitype was distinctly associated with neuroendocrine tumors (LCNEC and SCLC). For adenocarcinoma, remaining four epitypes were associated with unsupervised and supervised gene expression phenotypes, and differences in molecular features including global hypomethylation, promoter hypermethylation, genomic instability, expression of proliferation-associated genes, and mutations in KRAS, TP53, KEAP1, SMARCA4, and STK11. Furthermore, these epitypes were associated with clinicopathological features such as smoking history, and patient outcome. Conclusions: Our findings highlight one neuroendocrine and four adenocarcinoma epitypes associated with molecular and clinicopathological characteristics, including patient outcome. This study highlights the possibility to further subgroup lung cancer, and more specifically adenocarcinomas, based on epigenetic/molecular classification that could lead to more accurate tumor classification, prognostication, and tailored patient therapy.
  •  
4.
  • Karlsson, Anna K, et al. (författare)
  • Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
  • 2015
  • Ingår i: Oncotarget. - 1949-2553. ; 6:26, s. 22028-22037
  • Tidskriftsartikel (refereegranskat)abstract
    • Large cell carcinoma with or without neuroendocrine features (LCNEC and LC, respectively) constitutes 3-9% of non-small cell lung cancer but is poorly characterized at the molecular level. Herein we analyzed 41 LC and 32 LCNEC (including 15 previously reported cases) tumors using massive parallel sequencing for mutations in 26 cancer-related genes and gene fusions in ALK, RET, and ROS1. LC patients were additionally subdivided into three immunohistochemistry groups based on positive expression of TTF-1/Napsin A (adenocarcinoma-like, n = 24; 59%), CK5/P40 (squamous-like, n = 5; 12%), or no marker expression (marker-negative, n = 12; 29%). Most common alterations were TP53 (83%), KRAS (22%), MET (12%) mutations in LCs, and TP53 (88%), STK11 (16%), and PTEN (13%) mutations in LCNECs. In general, LCs showed more oncogene mutations compared to LCNECs. Immunomarker stratification of LC revealed oncogene mutations in 63% of adenocarcinoma-like cases, but only in 17% of marker-negative cases. Moreover, marker-negative LCs were associated with inferior overall survival compared with adenocarcinoma-like tumors (p = 0.007). No ALK, RET or ROS1 fusions were detected in LCs or LCNECs. Together, our molecular analyses support that LC and LCNEC tumors follow different tumorigenic paths and that LC may be stratified into molecular subgroups with potential implications for diagnosis, prognostics, and therapy decisions.
  •  
5.
  • Staaf, Johan, et al. (författare)
  • Relation between smoking history and gene expression profiles in lung adenocarcinomas
  • 2012
  • Ingår i: BMC Medical Genomics. - : Springer Science and Business Media LLC. - 1755-8794. ; 5
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Lung cancer is the worldwide leading cause of death from cancer. Tobacco usage is the major pathogenic factor, but all lung cancers are not attributable to smoking. Specifically, lung cancer in never-smokers has been suggested to represent a distinct disease entity compared to lung cancer arising in smokers due to differences in etiology, natural history and response to specific treatment regimes. However, the genetic aberrations that differ between smokers and never-smokers' lung carcinomas remain to a large extent unclear. Methods: Unsupervised gene expression analysis of 39 primary lung adenocarcinomas was performed using Illumina HT-12 microarrays. Results from unsupervised analysis were validated in six external adenocarcinoma data sets (n=687), and six data sets comprising normal airway epithelial or normal lung tissue specimens (n=467). Supervised gene expression analysis between smokers and never-smokers were performed in seven adenocarcinoma data sets, and results validated in the six normal data sets. Results: Initial unsupervised analysis of 39 adenocarcinomas identified two subgroups of which one harbored all never-smokers. A generated gene expression signature could subsequently identify never-smokers with 79-100% sensitivity in external adenocarcinoma data sets and with 76-88% sensitivity in the normal materials. A notable fraction of current/former smokers were grouped with never-smokers. Intriguingly, supervised analysis of never-smokers versus smokers in seven adenocarcinoma data sets generated similar results. Overlap in classification between the two approaches was high, indicating that both approaches identify a common set of samples from current/former smokers as potential never-smokers. The gene signature from unsupervised analysis included several genes implicated in lung tumorigenesis, immune-response associated pathways, genes previously associated with smoking, as well as marker genes for alveolar type II pneumocytes, while the best classifier from supervised analysis comprised genes strongly associated with proliferation, but also genes previously associated with smoking. Conclusions: Based on gene expression profiling, we demonstrate that never-smokers can be identified with high sensitivity in both tumor material and normal airway epithelial specimens. Our results indicate that tumors arising in never-smokers, together with a subset of tumors from smokers, represent a distinct entity of lung adenocarcinomas. Taken together, these analyses provide further insight into the transcriptional patterns occurring in lung adenocarcinoma stratified by smoking history.
  •  
6.
  •  
7.
  • Fagerlund, Göran, et al. (författare)
  • Betong som byggnadsmaterial
  • 1999
  • Ingår i: Betong och miljö : fakta från Betongforum. - 9173329061 ; , s. 14-48
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
8.
  • Gatzinsky, Vladimir, 1966, et al. (författare)
  • Long-term respiratory symptoms following esophageal atresia.
  • 2011
  • Ingår i: Acta Paediatrica. - : Wiley. - 0803-5253. ; 100:9, s. 1222-1225
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Oesophageal atresia (OA) is a congenital malformation that can lead to persistent respiratory symptoms in adulthood. Aim: To describe the prevalence of respiratory symptoms in adulthood in a population-based study of patients with repaired OA and to compare this with the prevalence in the general population. Methods: Of 80 patients operated for OA in Gothenburg in 1968–1983, 79 were located. The patients received a questionnaire on respiratory symptoms. Controls were 4979 gender- and age-matched subjects who answered the same questions. Results: The questionnaire was answered by 73 of 79 (92%) patients. Physician-diagnosed asthma was reported by 30% in the OA group vs 10% in the control group (OR 4.1; 95% CI 2.4–6.8), and recurrent wheeze in 29% vs 5.5% (OR 6.9; 4.1–11.6). Also wheeze during the last year, asthma medication, a long-standing cough, cough with sputum production and chronic bronchitis were significantly more common among the patients with OA. In contrast, there was no significant difference regarding risk factors for asthma. The prevalence of respiratory symptoms did not appear to decrease with age. Conclusion: A high prevalence of respiratory symptoms remains among adult patients with repaired OA. Many of the patients had an asthma diagnosis. However, asthma heredity or allergic rhinitis was not overrepresented.
  •  
9.
  • Guzzi, Nicola, et al. (författare)
  • Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
  • 2018
  • Ingår i: Cell. - : Elsevier BV. - 0092-8674 .- 1097-4172. ; 173:5, s. 26-1216
  • Tidskriftsartikel (refereegranskat)abstract
    • Pseudouridylation (Ψ) is the most abundant and widespread type of RNA epigenetic modification in living organisms; however, the biological role of Ψ remains poorly understood. Here, we show that a Ψ-driven posttranscriptional program steers translation control to impact stem cell commitment during early embryogenesis. Mechanistically, the Ψ “writer” PUS7 modifies and activates a novel network of tRNA-derived small fragments (tRFs) targeting the translation initiation complex. PUS7 inactivation in embryonic stem cells impairs tRF-mediated translation regulation, leading to increased protein biosynthesis and defective germ layer specification. Remarkably, dysregulation of this posttranscriptional regulatory circuitry impairs hematopoietic stem cell commitment and is common to aggressive subtypes of human myelodysplastic syndromes. Our findings unveil a critical function of Ψ in directing translation control in stem cells with important implications for development and disease. Translational control in stem cells is orchestrated by pseudouridylation of specific tRNA-derived fragments, impacting stem cell commitment during key developmental processes.
  •  
10.
  •  
11.
  •  
12.
  • Lindquist, Kajsa Ericson, et al. (författare)
  • Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
  • 2017
  • Ingår i: Oncotarget. - : Impact Journals, LLC. - 1949-2553. ; 8:21, s. 34796-34810
  • Tidskriftsartikel (refereegranskat)abstract
    • Precision medicine requires accurate multi-gene clinical diagnostics. We describe the implementation of an Illumina TruSight Tumor (TST) clinical NGS diagnostic framework and parallel validation of a NanoString RNA-based ALK, RET, and ROS1 gene fusion assay for combined analysis of treatment predictive alterations in non-small cell lung cancer (NSCLC) in a regional healthcare region of Sweden (Scandinavia). The TST panel was clinically validated in 81 tumors (99% hotspot mutation concordance), after which 533 consecutive NSCLCs were collected during one-year of routine clinical analysis in the healthcare region (~90% advanced stage patients). The NanoString assay was evaluated in 169 of 533 cases. In the 533-sample cohort 79% had 1-2 variants, 12% >2 variants and 9% no detected variants. Ten gene fusions (five ALK, three RET, two ROS1) were detected in 135 successfully analyzed cases (80% analysis success rate). No ALK or ROS1 FISH fusion positive case was missed by the NanoString assay. Stratification of the 533-sample cohort based on actionable alterations in 11 oncogenes revealed that 66% of adenocarcinomas, 13% of squamous carcinoma (SqCC) and 56% of NSCLC not otherwise specified harbored ≥1 alteration. In adenocarcinoma, 10.6% of patients (50.3% if including KRAS) could potentially be eligible for emerging therapeutics, in addition to the 15.3% of patients eligible for standard EGFR or ALK inhibitors. For squamous carcinoma corresponding proportions were 4.4% (11.1% with KRAS) vs 2.2%. In conclusion, multiplexed NGS and gene fusion analyses are feasible in NSCLC for clinical diagnostics, identifying notable proportions of patients potentially eligible for emerging molecular therapeutics.
  •  
13.
  • Walkowska, Joanna, et al. (författare)
  • Immunoprofiles of colorectal cancer from Lynch syndrome
  • 2019
  • Ingår i: OncoImmunology. - 2162-4011. ; 8:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Colorectal cancers associated with Lynch syndrome are characterized by defective mismatch repair, microsatellite instability, high mutation rates, and a highly immunogenic environment. These features define a subset of cancer with a favorable prognosis and high likelihood to respond to treatment with anti-programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) drugs. With the aim to define immune-evasive mechanisms and a potential impact hereof in colorectal cancers from Lynch syndrome versus hereditary cases with retained mismatch repair function, we immunohistochemically and transcriptionally profiled 270 tumors. Lynch syndrome-associated tumors showed an overrepresentation of tumor-infiltrating CD3, CD8 and CD68 positive cells, loss of beta-2-microglobulin (B2M) and up-regulation of PD-L1 on tumor cells. The gene expression signature of Lynch syndrome tumors was characterized by upregulation of genes related to antigen processing and presentation, apoptosis, natural killer cell-mediated cytotoxicity, and T cell activation. Tumors with loss of B2M and up-regulation of PD-L1 showed distinctive immunogenic profiles. In summary, our data demonstrate a complex tumor-host interplay where B2M loss and PD-L1 up-regulation influence immunological pathways and clinical outcome in Lynch syndrome tumors. Immunological classification may thus aid in the preselection of colorectal cancers relevant for treatment with anti-PD-1/PD-L1 therapies.
  •  
14.
  • Akbarnejad, Shahin, 1978-, et al. (författare)
  • A Computational Fluid Dynamics Study on Physical Refining of Steel Melts by Filtration
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • In this paper, a previous experimental investigation on physical refining of steel melts by filtration was numerically studied. To be specific, filtration of non-metallic alumina inclusions, in the size range of 1 to 100 [μm], from steel melt by using a square-celled monolithic alumina filter was simulated. Computational fluid dynamics (CFD) studies, including simulations of both fluid flow and particle tracing using one-way coupling method, were conducted. The CFD predicted results for particles in the size range  5 [μm] were compared to the published experimental data. The modelled filtration setup could capture 100 % of the particles larger than 50 [μm]. The percentage of the filtered particles decreases from 98% to 0% in the particle size range of 50 [μm] to 1[μm].
  •  
15.
  • Akbarnejad, Shahin, et al. (författare)
  • Effect of Fluid Bypassing on the Experimentally Obtained Darcy and Non-Darcy Permeability Parameters of Ceramic Foam Filters
  • 2017
  • Ingår i: Metallurgical and materials transactions. B, process metallurgy and materials processing science. - : Springer. - 1073-5615 .- 1543-1916. ; 48:1, s. 197-207
  • Tidskriftsartikel (refereegranskat)abstract
    • Ceramic foam filters (CFFs) are used to remove solid particles and inclusions from molten metal. In general, molten metal which is poured on the top of a CFF needs to reach a certain height to build the required pressure (metal head) to prime the filter. To estimate the required metal head, it is necessary to obtain permeability coefficients using permeametry experiments. It has been mentioned in the literature that to avoid fluid bypassing, during permeametry, samples need to be sealed. However, the effect of fluid bypassing on the experimentally obtained pressure gradients seems not to be explored. Therefore, in this research, the focus was on studying the effect of fluid bypassing on the experimentally obtained pressure gradients as well as the empirically obtained Darcy and non-Darcy permeability coefficients. Specifically, the aim of the research was to investigate the effect of fluid bypassing on the liquid permeability of 30, 50, and 80 pores per inch (PPI) commercial alumina CFFs. In addition, the experimental data were compared to the numerically modeled findings. Both studies showed that no sealing results in extremely poor estimates of the pressure gradients and Darcy and non-Darcy permeability coefficients for all studied filters. The average deviations between the pressure gradients of the sealed and unsealed 30, 50, and 80 PPI samples were calculated to be 57.2, 56.8, and 61.3 pct. The deviations between the Darcy coefficients of the sealed and unsealed 30, 50, and 80 PPI samples found to be 9, 20, and 31 pct. The deviations between the non-Darcy coefficients of the sealed and unsealed 30, 50, and 80 PPI samples were calculated to be 59, 58, and 63 pct.
  •  
16.
  • Al-Saadi, Munir, 1965- (författare)
  • Thermomechanical Processing of Nickel-Base Alloy 825
  • 2021
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Alloy 825 material was studied using a Gleeble-3800 thermosimulatorby performing single-hot compression experiments.Optical microscopy and electron backscatter diffraction wereutilized to characterize the microstructure. Dynamicrecrystallization is not considerable in the as-cast alloy anddislocation recovery is deemed to be dominant. Based on thisfinding, the effect of adding trace amounts of alloying additionson the mechanical properties of cast alloy 825 was studied, withemphasis on whether or not dynamic recrystallization occurred.The results show that dynamic recrystallization was moreprevalent under all test conditions in samples containing a traceamount of magnesium, but not for the conventional alloy.However, alloying with trace magnesium did not lead to animprovement of the mechanical properties. Instead, processingmaps for hot forging of conventional Alloy 825 were required toidentify optimal working parameters and to achieve dynamicrecrystallization. The hot deformation behavior of cast Alloy 825was characterized by using dynamic materials modelling of hotcompression data. The results show that the maximum powerdissipation efficiency is over 35%. The highest efficiency isachieved in the temperature range of 1100 ℃ - 1250 ℃ and instrain rates in the range of 0.01 ≤ strain rate / s ≤ 0.1. The optimumprocessing parameters for good strain hardening are obtained inthe temperature range between 950 ℃ and 1100 ℃ with strainrates of 0.3 ≤ strain rate/ s ≤ 10.0. In addition, the influence of thedeformation level on the recrystallization and microstructuralchanges in Alloy 825 during hot forging operations attemperatures between 950 °C and 1200 °C was studied. Themaximum yield strength and ultimate tensile strength wereobtained after forging to achieve a true strain of 0.9 were 413 MPa and 622 MPa , respectively, with a ductility of 40%.However, Alloy 825 is often supplied as annealed bars.Therefore, the effect of the forging strain magnitude andsubsequent annealing on the microstructure, strengtheningmechanisms and room temperature mechanical properties wereinvestigated to assess the suitability of current industrialpractice. The results showed that the majority of strengtheningwas attributed to grain refinement, the dislocation densities thatarise due to the large forging strain, and due to solid solutionstrengthening. The results of calculations are in excellentagreement with experimental data, with less than 1% difference.These results can be used by future researchers and industry topredict the strength of Alloy 825 and similar alloys, especially inmaterial after a completed hot forging operation.
  •  
17.
  • Andréasson, Kristofer, et al. (författare)
  • Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C
  • 2015
  • Ingår i: Infectious Diseases. - : Informa UK Limited. - 2374-4243 .- 2374-4235. ; 47:12, s. 915-918
  • Tidskriftsartikel (refereegranskat)abstract
    • Cartilage oligomeric matrix protein (COMP) is a biomarker of fibrosis in lung and skin. In this exploratory study we investigated the biomarker potential of COMP in chronic hepatitis C (CHC). We included consecutive patients with CHC admitted to the Department of Infectious Diseases, Lund University Hospital. COMP was analysed in serum using ELISA. The correlations between COMP and liver fibrosis, determined by transient elastography (TE) (n = 47) and liver biopsy (n = 28) were assessed. We also studied COMP prospectively in relation to antiviral treatment (n = 10). COMP correlated with the degree of liver fibrosis as assessed by TE (r = 0.71, p < 0.001) and liver biopsy (r(s) = 0.65, p < 0.001). After successful treatment of CHC, COMP decreased from 18 to 13 U/l (p = 0.011). We suggest that COMP is associated with the stage of liver fibrosis in CHC. The biomarker potential of COMP in CHC warrants further investigation.
  •  
18.
  •  
19.
  • Andréasson, Kristofer, et al. (författare)
  • Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease
  • 2016
  • Ingår i: Arthritis Research and Therapy. - : Springer Science and Business Media LLC. - 1478-6354 .- 1478-6362. ; 18:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Recent evidence suggests a link between autoimmunity and the intestinal microbial composition in several rheumatic diseases including systemic sclerosis (SSc). The objective of this study was to investigate the prevalence of intestinal dysbiosis in SSc and to characterise patients suffering from this potentially immunomodulatory deviation. Methods: This study consisted of 98 consecutive patients subject to in-hospital care. Stool samples were analysed for intestinal microbiota composition using a validated genome-based microbiota test (GA-map™ Dysbiosis Test, Genetic Analysis, Oslo, Norway). Gut microbiota dysbiosis was found present as per this standardised test. Patients were examined regarding gastrointestinal and extraintestinal manifestations of SSc by clinical, laboratory, and radiological measures including esophageal cineradiography, the Malnutrition Universal Screening Tool (MUST), levels of plasma transthyretin (a marker of malnutrition) and faecal (F-) calprotectin (a marker of intestinal inflammation). Results: A majority (75.5%) of the patients exhibited dysbiosis. Dysbiosis was more severe (rs=0.31, p=0.001) and more common (p=0.013) in patients with esophageal dysmotility. Dysbiosis was also more pronounced in patients with abnormal plasma levels of transthyretin (p=0.045) or micronutrient deficiency (p=0.009). In 19 patients at risk for malnutrition according to the MUST, 18 exhibited dysbiosis. Conversely, of the 24 patients with a negative dysbiosis test, only one was at risk for malnutrition. The mean±SEM levels of F-calprotectin were 112±14 and 45±8μg/g in patients with a positive and negative dysbiosis test, respectively. Dysbiosis was more severe in patients with skin telangiectasias (p=0.020), pitting scars (p=0.023), pulmonary fibrosis (p=0.009), and elevated serum markers of inflammation (p<0.001). However, dysbiosis did not correlate with age, disease duration, disease subtype, or extent of skin fibrosis. Conclusions: In this cross-sectional study, intestinal dysbiosis was common in patients with SSc and was associated with gastrointestinal dysfunction, malnutrition and with some inflammatory, fibrotic and vascular extraintestinal features of SSc. Further studies are needed to elucidate the potential causal relationship of intestinal microbe-host interaction in this autoimmune disease.
  •  
20.
  • Andréasson, Kristofer, et al. (författare)
  • Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
  • 2019
  • Ingår i: World Journal of Hepatology. - : Baishideng Publishing Group Inc.. - 1948-5182. ; 11:3, s. 330-334
  • Tidskriftsartikel (refereegranskat)abstract
    • Serum levels of cartilage oligomeric matrix protein (COMP) has been presented as a biomarker of liver fibrosis in several cross-sectional studies. COMP is also an essential mediator in carcinoma development and has also been associated with hepatocellular carcinoma. We present a prospective analysis of this biomarker in 38 patients with chronic hepatitis C who were subject to eradication therapy with direct acting antivirals. We confirm previous studies associating COMP elevation with liver cirrhosis. We also show how viral levels are correlated with COMP at baseline. In our prospective analysis, we report that successful eradication of hepatitis C results in improvement in liver stiffness and laboratory liver function tests at 1 year follow-up. In contrast, median COMP-levels remain unchanged during the study period. We conclude that the biomarker potential of COMP in the prospective evaluation of liver diseases, remains to be elucidated.
  •  
21.
  •  
22.
  • Andreou, Dimitrios, et al. (författare)
  • Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers
  • 2011
  • Ingår i: European Neuropsychopharmacology. - : Elsevier BV. - 0924-977X .- 1873-7862. ; 21:9, s. 700-704
  • Tidskriftsartikel (refereegranskat)abstract
    • The dystrobrevin binding protein-1 (DTNBP1) gene encodes dysbindin-1, a protein involved in neurodevelopmental and neurochemical processes related mainly to the monoamine dopamine. We investigated possible associations between eleven DTNBP1 polymorphisms and cerebrospinal fluid (CSF) concentrations of the major dopamine metabolite homovanillic acid (HVA), the major serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), and the major noradrenaline metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) in healthy human subjects (n=132). Two polymorphisms, rs2619538 and rs760666, were nominally associated with CSF HVA and 5-HIAA concentrations, whereas a third polymorphism, rs909706, showed association only with HVA. After correction for multiple testing only the associations between rs2619538 and HVA and 5-HIAA concentrations remained significant. No significant association was found between any of the investigated DTNBP1 polymorphisms and CSF MHPG concentrations. The results suggest that genetic variation in DTNBP1 gene affects the regulation of dopamine and serotonin turnover in the central nervous system of healthy volunteers.
  •  
23.
  • Andreou, Dimitrios, et al. (författare)
  • Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis
  • 2014
  • Ingår i: Behavioral and Brain Functions. - : Springer Science and Business Media LLC. - 1744-9081. ; 10, s. 26-
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are the major monoamine metabolites in the central nervous system (CNS). Their cerebrospinal fluid (CSF) concentrations, reflecting the monoamine turnover rates in CNS, are partially under genetic influence and have been associated with schizophrenia. We have hypothesized that CSF monoamine metabolite concentrations represent intermediate steps between single nucleotide polymorphisms (SNPs) in genes implicated in monoaminergic pathways and psychosis.METHODS: We have searched for association between 119 SNPs in genes implicated in monoaminergic pathways [tryptophan hydroxylase 1 (TPH1), TPH2, tyrosine hydroxylase (TH), DOPA decarboxylase (DDC), dopamine beta-hydroxylase (DBH), catechol-O-methyltransferase (COMT), monoamine oxidase A (MAOA) and MAOB] and monoamine metabolite concentrations in CSF in 74 patients with psychotic disorder.RESULTS: There were 42 nominally significant associations between SNPs and CSF monoamine metabolite concentrations, which exceeded the expected number (20) of nominal associations given the total number of tests performed. The strongest association (p = 0.0004) was found between MAOB rs5905512, a SNP previously reported to be associated with schizophrenia in men, and MHPG concentrations in men with psychotic disorder. Further analyses in 111 healthy individuals revealed that 41 of the 42 nominal associations were restricted to patients with psychosis and were absent in healthy controls.CONCLUSIONS: The present study suggests that altered monoamine turnover rates in CNS reflect intermediate steps in the associations between SNPs and psychosis.
  •  
24.
  • Andreou, Dimitrios, et al. (författare)
  • Tryptophan hydroxylase gene 1 (TPH1) variants associated with cerebrospinal fluid 5-hydroxyindole acetic acid and homovanillic acid concentrations in healthy volunteers
  • 2010
  • Ingår i: Psychiatry Research. - : Elsevier BV. - 0165-1781 .- 1872-7123. ; 180:2-3, s. 63-67
  • Tidskriftsartikel (refereegranskat)abstract
    • Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin synthesis. We investigated possible relationships between five TPH1 gene polymorphisms and cerebrospinal fluid (CSF) concentrations of the major serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the major dopamine metabolite homovanillic acid (HVA), and the major norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) in healthy volunteers (n = 132). The G-allele of the TPH1 rs4537731 (A-6526G) polymorphism was associated with 5-HIM and HVA, but not MHPG concentrations. None of the other four TPH1 polymorphisms (rs211105, rs1800532, rs1799913 and rs7933505) were significantly associated with any of the monoamine metabolite concentrations. Two (rs4537731G/rs211105T/rs1800532C/rs1799913C/rs7933505G and rs4537731A/rs211105T/rs1800532C/rs1799913C/rs7933505G) of five common TPH1 five-allele haplotypes were associated with 5-HIAA and HVA concentrations in opposite directions. None of the common haplotypes was associated with MHPG concentrations in the CSF. The results suggest that TPH1 gene variation participates in the regulation of serotonin and dopamine turnover rates in the central nervous system of healthy human subjects.
  •  
25.
  • Aoude, Lauren G., et al. (författare)
  • A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
  • 2013
  • Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 8:8
  • Tidskriftsartikel (refereegranskat)abstract
    • Truncating germline mutations in the tumor suppressor gene BRCA-1 associated protein-1 (BAP1) have been reported in families predisposed to developing a wide range of different cancer types including uveal melanoma and cutaneous melanoma. There has also been an association between amelanotic tumor development and germline BAP1 mutation suggesting a possible phenotypic characteristic of BAP1 mutation carriers. Though there have been many types of cancer associated with germline BAP1 mutation, the full spectrum of disease association is yet to be ascertained. Here we describe a Danish family with predominantly uveal melanoma but also a range of other tumor types including lung, neuroendocrine, stomach, and breast cancer; as well as pigmented skin lesions. Whole-exome sequencing identified a BAP1 splice mutation located at c.581-2A>G, which leads to a premature truncation of BAP1 in an individual with uveal melanoma. This mutation was carried by several other family members with melanoma or various cancers. The finding expands on the growing profile of BAP1 as an important uveal and cutaneous melanoma tumor suppressor gene and implicates its involvement in the development of lung, and stomach cancer.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-25 av 393
Typ av publikation
tidskriftsartikel (295)
konferensbidrag (39)
bokkapitel (16)
annan publikation (14)
doktorsavhandling (11)
forskningsöversikt (7)
visa fler...
rapport (6)
bok (3)
samlingsverk (redaktörskap) (1)
licentiatavhandling (1)
visa färre...
Typ av innehåll
refereegranskat (327)
övrigt vetenskapligt/konstnärligt (62)
populärvet., debatt m.m. (4)
Författare/redaktör
Jönsson, Göran B (97)
Jönsson, Göran (79)
Jönsson, Pär Göran (70)
Staaf, Johan (47)
Olsson, Håkan (46)
Borg, Åke (44)
visa fler...
Ingvar, Christian (39)
Lauss, Martin (37)
Harbst, Katja (30)
Ringnér, Markus (29)
Vallon-Christersson, ... (23)
Nakajima, Keiji (16)
Truedsson, Lennart (15)
Jirström, Karin (15)
Karasev, Andrey (15)
Carneiro, Ana (14)
Bendahl, Pär Ola (13)
Jönsson, Anders (13)
Svane, Inge Marie (13)
Donia, Marco (13)
Baldetorp, Bo (12)
Broman, Göran (12)
Lundgren, Lotta (12)
Rosengren, Frida (11)
Ersson, Mikael (11)
Tsao, Hensin (11)
Isaksson, Karolin (11)
Holm, Karolina (11)
Marko-Varga, György (10)
Mitra, Shamik (10)
Hayward, Nicholas K (10)
Dalin, Göran (10)
Roepstorff, Lars (10)
Egenvall, Agneta (10)
Lindberg, Lars-Göran ... (10)
Philipsson, Jan (10)
Jönsson, Björn, 1951 ... (10)
Näsholm, Anna (10)
Jönsson, Lina (10)
Jönsson, Christer (9)
Nielsen, Kari (9)
Thor, Göran (9)
Hansson, Johan (9)
Welinder, Charlotte (9)
Mu, Wangzhong (9)
Jönsson, Mari (9)
Saxne, Tore (9)
Rezeli, Melinda (9)
Hegardt, Cecilia (9)
Jönsson, Lars, 1955 (9)
visa färre...
Lärosäte
Lunds universitet (226)
Kungliga Tekniska Högskolan (81)
Karolinska Institutet (36)
Göteborgs universitet (29)
Linköpings universitet (24)
Sveriges Lantbruksuniversitet (21)
visa fler...
Uppsala universitet (14)
Blekinge Tekniska Högskola (12)
Umeå universitet (10)
RISE (10)
Stockholms universitet (7)
Örebro universitet (3)
Gymnastik- och idrottshögskolan (3)
Högskolan Dalarna (3)
Handelshögskolan i Stockholm (2)
Chalmers tekniska högskola (2)
Luleå tekniska universitet (1)
Malmö universitet (1)
visa färre...
Språk
Engelska (371)
Svenska (22)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (218)
Teknik (101)
Samhällsvetenskap (25)
Naturvetenskap (23)
Lantbruksvetenskap (17)
Humaniora (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy